CASI Pharmaceuticals
CASI
#11079
Rank
NZ$7.41 M
Marketcap
NZ$0.36
Share price
0.00%
Change (1 day)
-87.31%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.82. In 2024 the company made an earnings per share (EPS) of NZ-$4.45 a decrease over its 2023 EPS that were of NZ-$3.51.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.654.44%
2024NZ-$4.4526.73%
2023NZ-$3.51-32.89%
2022NZ-$5.2411.9%
2021NZ-$4.68-38.44%
2020NZ-$7.60-8.96%
2019NZ-$8.3550%
2018NZ-$5.5777.78%
2017NZ-$3.135.88%
2016NZ-$2.96-22.73%
2015NZ-$3.83-76.09%
2014NZ-$16.00318.18%
2013NZ-$3.83-71.79%
2012NZ-$13.5765.96%
2011NZ-$8.18-50%
2010NZ-$16.35-18.97%
2009NZ-$20.18-63.64%
2008NZ-$55.493.57%
2007NZ-$53.58-60.56%
2006NZ-$135.8697.22%
2005NZ-$68.89-2.7%
2004NZ-$70.80-45.59%
2003NZ-$130.12-61.8%
2002NZ-$340.61-25.52%
2001NZ-$457.34-21.38%
2000NZ-$581.7213.86%
1999NZ-$510.92149.53%
1998NZ-$204.7598.15%
1997NZ-$103.3310.2%
1996NZ-$93.76